VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Standalone and Consolidated Unaudited Financial Results for 1st quarter ended 30th June 2023, published in Financial Express (English) and Andhra Prabha (Telugu) on 29th July 2023. Q1FY24 Quarterly Result Announced for Vimta Labs Ltd.
Healthcare Services company Vimta Labs announced Q1FY24 results: Total Income for Q1FY24 was at Rs 841 million EBITDA for Q1FY24 was Rs 252 million; EBITDA margin remained steady at 30.0% Q1FY24 PAT was at Rs 122 million; PAT Margins for the quarter was at 14.5% Basic EPS was at Rs 5.5 in Q1FY24 as against Rs 5.4 in Q1FY23 Total Debt as of 30th June 2023 stood at Rs 137 million down from Rs 150 million as of 31st March 2023 Cash and Cash equivalents were at Rs 285 million as of 30th June 2023 Q1FY24 Capex was at Rs 218 million Debt to Equity ratio was 0.05x Commenting on results, Harita Vasireddi, Managing Director, Vimta Labs, said: “We are extremely pleased with the continued growth momentum despite a challenging external environment. During Q1FY24, our total income was Rs 841 million. The Pharma segment led the growth during the quarter with the food segment getting impacted due to the Biparjoy cyclone whereas other segments remained stable. While the external environment remains uncertain, robust demand in the TIC market gives us the confidence of delivering strong growth in the coming quarters” Result PDF VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q1 Results FY2023-24 VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Q1 FY24 Results. VIMTA LABS LTD.-$ - 524394 - Standalone And Consolidated Unaudited Financial Results For The 1St Quarter Ended 30Th June 2023.
Standalone and Consolidated Unaudited Financial Results for the 1st quarter ended 30th June 2023. VIMTA LABS LTD.-$ - 524394 - Board Meeting Outcome for For The 1St Quarter Ended 30.06.2023.
Outcome of Board Meeting for the 1st quarter ended 30.06.2023. VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/Investor Conference call post Announcement of Q1 results for the FY 2023-24 on 31.07.2023 at 11:00 AM. VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 4530 equity shares under Vimta Labs Employee Stock Option Plan 2021. VIMTA LABS LTD.-$ - 524394 - Board Meeting Intimation for Consider, Approve Interalia, And Take On Record The Standalone And Consolidated Unaudited Financial Results For The First Quarter Ended 30Th June 2023.
VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2023 ,inter alia, to consider and approve the standalone unaudited financial results and consolidated unaudited financial results for the first quarter ended 30th June 2023. VIMTA LABS LTD.-$ - 524394 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 30th June 2023.